Venture Leaders 2017

After a very competitive process, a group of Switzerland’s most innovative start-ups has been selected for an action-packed journey to the US. This is part of the program Venture Leaders, co-organized by venturelab and swissnex Boston.

Life Sciences

The venture leaders in Life Sciences were composed of 10 high potential startups and who flew to Boston for a “business boosting” week that enabled them to accelerate their development in the US market and meet top investors and experts, as well as participate in hands-on workshops.

2017 Venture Leaders Life Sciences

Venture Leaders Life Sciences (Boston, June 11-17)

Rodrigo Araujo, ComphyaComphya developed an active implantable medical device to restore the erectile function of patients who are non-responsive to oral drugs- primarily focusing on patients with spinal cord injury.(medtech), EPF Lausanne
Patrizia Marschalkova, DriconisLymphedema is a frequently occurring and serious complication of cancer therapies. It is a chronic and progressive disease. Dicronis helps to drastically improve its prognosis by providing the earliest lymphedema diagnostic based on a micro-needle technology used to assess the lymphatic function in a simple, safe, minimally-invasive and cost-effective manner. (medtech), ETHZ
Georges Muller, DispencellBiotech companies spend USD 220 million per year in isolating the best candidate living cell for making new drugs. With the technology of Dispencell, they will be able to isolate single cell lines three times faster and ten times cheaper than with existing solutions. (biotech) EPF Lausanne
Andreas Schmocker, LumigboEvery day, more than 1 million implants are placed using open surgery. Lumigbo developed a technology to build up implants inside the body using an access channel of less than half a millimeter in diameter. The procedure can be used for almost any type of polymer-based implant.(medtech), EPF Lausanne
Urs Frey, MaxWell BioSystemsMaxWell BioSystems provides the most advanced electrophysiology instrumentation for high-throughput cell assays to accelerate drug discovery and advance basic research. Their toolset, consisting of an integrated sensor chip, acquisition hardware and software, can be applied in personalized medicine, e.g. using patient stem cell derived neurons for preclinical drug discovery.(mircotechnologies/biotech), ETHZ
Raphael Hostettler, Medical TemplatesMedical Templates developed the “Puncture Cube”, an ingeniously simple approach to computed tomography guided needle navigation for biopsies & pain therapy.Medical Templates is now aiming towards FDA approval by the End of 2017 to enter the US market. (medtech), ETHZ
Carlos Ciller, RetinAI MedicalBern-based RetinAI Medical focuses on empowering eye care professionals and doctors using artificial intelligence. They use the latest machine learning techniques & medical image processing to reach human-level performance for the assisted automatic evaluation of Optical Coherence Tomography (OCT), Fundus Image Photography and retinal Angiography. These techniques can be applied to the early detection and screening of the following pathologies: Age-related Macular Degeneration (AMD), Diabetic Retinopathy (DR), Glaucoma, and a multitude of neurodegenerative diseases.(medtech), UNIL
Francesco Petrini, SensArsLower limb amputees suffer from a lack of sensory feedback from prostheses causeing falls and asymmetrical walking causing high fatigue. They can also contract phantom limb pain. Due to such inconveniences, 60% of the amputees abandon their prosthesis. SensArs’ solution is SENSY, a unique worldwide product which allows amputees to naturally feel their missing limbs. (medtech), EPF Lausanne
Ivana Balic, SonoViewSonoView develops an accurate, safe and cost-effective imaging technology to help health professionals detect breast cancer at an earlier and more treatable stage. The technology aims at obtaining the same image quality as Magnetic Resonance Scanning at 1/10th of its cost. (medtech), EPF Lausanne
Mattias Larsson, SUINCoLSUINCoL develops tissue regeneration therapies, with the primary focus on non-invasive treatment of stress urinary incontinence. SUINCoL’s main goal is to motivate investors to fund further development of its products and their respective clinical introduction.(biotech), EPF Lausanne


The 10 selected entrepreneurs reflect the acceleration of the Swiss Fintech scene in recent years and the impressive quality of its startups. The intense journey took place from September 10 to 16 in New York. The roadshow offered an accelerated learning curve and a solid network through exchanges with their peers in the team, as well as market exposure, pitching to investors and experts, and hands-on business development. Not only did they attend Finovate, the largest Fintech conference, but also met with several US investors and had an open demo night, to show the New York audience that Switzerland does not need to hide when it comes to the quality of its startups.

2017 Venture Leaders Fintech


Advanon, Phil Lojacono
Advanon in its basic version is an online platform that allows SMEs to pre-finance their open invoices directly through financial investors. Thereby they don’t have to wait for the long payment terms anymore and investors, on the other hand, get access to a new type of asset class. In the long run, Advanon wants to make financing for SMEs redundant and fully automated.

AlgoTrader, Andy Flury
The startup provides an algorithmic trading software that allows automation of complex, quantitative trading strategies. AlgoTrader provides everything a typical hedge fund needs on a daily basis to run his operation. They help trading companies minimize manual labor and save costs. Their software AlgoTrader is the first and only algorithmic trading software to be available both on the cloud and on-premise.

Carbon Delta, Oliver Marchand
Carbon Delta is a climate risk specialist that identifies and analyzes the climate change resilience of publicly traded companies. They assess a company’s Climate Value-at-Risk (VaR), thus how much its market value will possibly be affected by climate change, to help investors manage the climate risk within their portfolio. The startup uses big data analysis and their research can be used to calculate the Climate VaR for thousands of equities and corporate bonds. Three core risk scenarios are currently used for calculating a company’s overall climate resilience: expected regulations, extreme weather events, and the Paris Agreement’s 2°C target.

CreditGate24, Teddy Amberg
CreditGate24 is an independent Swiss company and a fully automated platform for lenders and borrowers which offers efficient, transparent and scalable credit processing at high quality. The startup operates online without physical branches and high operating expenses to enhance returns for lenders and lower costs for borrowers. CreditGate24 stands for a stringent underwriting process, based on established credit assessment tools, big data and social media analyses as well as insurance against risk of death and risk pooling to reduce loss risks. CreditGate24 is supervised by the Financial Services Standards Association VQF, is a registered financial intermediary under the Swiss Anti-Money Laundering Act and possesses a loan provision license (“Kreditvergabelizenz”).

Futurae Technologies, Samuel Berger
Futurae empowers companies to deploy state-of-the-art IT security while improving the customer journey. Through user-friendly solutions, businesses can increase their customers’ satisfaction while gaining confidence in their ability to protect sensitive user data. Users choose weak passwords and reuse the same passwords for various applications. Futurae offers a complete strong Authentication Suite (2FA) for securing sensitive end-user data of every organization. Their product portfolio offers a high level of security while making 2FA more user-friendly and making the integration fast and cost-effective for companies. Futurae grew from within the research institutes of ETH and is now being led by top-of-class individuals with a vision.

KiWi (eBOP), Christian Sinobas
KiWi transforms merchant’s phone into a smart point of sale. KiWi is the app small merchants use in emerging markets to accept card payments, finance their working capital, sell new services and better control their businesses. The company is live in Mexico with >2’000 paying merchants enrolled. The ambition is to quickly reach several hundreds of thousands of micro-merchants in Mexico and to open five new markets by 2020.

Monito (Global Impact Finance), Francois Briod
Sending money abroad? Monito is the for money transfers, helping migrants and expatriates find, review and compare money transfer services. They are on a mission to change the industry for the better and free the world of $28bn excessive transfer fees paid each year.

OneVisage, Christophe Remillet
OneVisage is a leading cyber-security company developing biometric solutions to help financial services eliminating identity theft and increasing user’s digital experience. They are first to offer 3D facial biometry on standard smartphones that delivers higher security than fingerprints at the price of password-based solutions.

Qumram, Patrick Barnert
Qumram seamlessly records all digital interactions, across all channels (web, social media, mobile and instant messaging) capturing indisputable evidence to prove compliance, discover fraud, improve customer experience and open new digital channels to interact with Financial Service clients. Banks such as UBS, HSBC, Bankia, Russell Investments, and many more trust Qumram today.

SONECT, Sandipan Chakraborty
SONECT enables every shop in the neighborhood to act as a virtual ATM. The APP is a location-aware, decentralized platform that brings together clients with stores. The gain is threefold: Shops attract more customers and therefore earn more money, without any costs. Everybody can withdraw cash at the click of a button wherever they are, for free, and banks reduce their ATM operations costs. SONECT recycles banknotes in circulation to reduce the cost of cash of banks and retailers while accelerating digital adoption of consumers.